Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amesite (AMST) Cash & Equivalents (2019 - 2025)

Amesite (AMST) has disclosed Cash & Equivalents for 7 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 124.24% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 124.24% year-over-year, with the annual reading at $2.3 million for FY2025, 12.67% up from the prior year.
  • Cash & Equivalents hit $1.2 million in Q4 2025 for Amesite, down from $1.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $12.1 million in Q1 2021 to a low of $519706.0 in Q4 2024.
  • Historically, Cash & Equivalents has averaged $5.4 million across 5 years, with a median of $4.9 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: soared 310.04% in 2021 and later plummeted 85.81% in 2024.
  • Year by year, Cash & Equivalents stood at $7.8 million in 2021, then decreased by 9.8% to $7.0 million in 2022, then tumbled by 47.6% to $3.7 million in 2023, then tumbled by 85.81% to $519706.0 in 2024, then skyrocketed by 124.24% to $1.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for AMST at $1.2 million in Q4 2025, $1.8 million in Q3 2025, and $2.3 million in Q2 2025.